EDMONTON, June 1 /CNW/ - Biomira Inc. (Nasdaq: BIOM) (TSX: BRA) today announced that Dr. Alex McPherson has stepped down from the Company's Board. Biomira's Corporate Governance Guidelines require non-independent directors to tender their resignation from the Board upon their resignation, removal or retirement as an Officer of the Company. Dr. McPherson stepped down as President and CEO on May 17, 2006 and tendered his resignation to the Corporate Governance Committee Chair shortly thereafter. The Board of Directors has accepted Dr. McPherson's resignation from the Company's Board. Eric Baker, Biomira's Chairman stated, "We thank Alex for his tireless dedication to the Company and the Board. Alex has been a part of Biomira's Board for 19 years and his contributions will be missed. Biomira is excited about its future and the Board is currently considering successors; we look forward to updating the market as soon as a decision is made." About Biomira Biomira is a biotechnology company specializing in the development of innovative therapeutic approaches to cancer management. Biomira's commitment to the treatment of cancer currently focuses on the development of synthetic vaccines and novel strategies for cancer immunotherapy. This release may contain forward-looking statements. Factors could cause actual results to differ materially from those projected in forward-looking statements. Although the Company believes that the forward-looking statements contained herein are reasonable, it can give no assurance that the Company's expectations are correct. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.